Compass Therapeutics Inc. <CMPX.O>: Leerink Partners Assumes Coverage With Outperform Rating; Target Price $4
CMPX•Related News
Equifax Inc <EFX.N>: RBC cuts target price to $194 from $222
EFX•
Charles Schwab Corp <SCHW.N>: JP Morgan raises target price to $144 from $137
SCHW•
Danaher Corp <DHR.N>: JP Morgan Cuts Target Price to $220 From $245
DHR•
Nvidia supplier Wistron launches $700 million Texas factory for AI system production
NVDA•
MSCI Inc cuts target price to $730 from $760
MSCI•